Content area

|
|

Behandling af infektioner forårsaget af vancomycinresistente enterokokker

Forfatter(e)

Lars Christian Lund1, Barbara Juliane Holzknecht2 & Ulrik Stenz Justesen1

1) Klinisk Mikrobiologisk Afdeling, Odense Universitetshospital 2) Klinisk Mikrobiologisk Afdeling, Herlev Hospital Ugeskr Læger 2018;180:V07170530

Reference: 
Ugeskr Læger 2018;180:V07170530
Blad nummer: 
Sidetal: 
2-6
Treatment of vancomycin-resistant enterococcal infections

Vancomycin-resistant enterococci (VRE) are a growing healthcare concern, and since 2012 the incidence has increased eightfold in Denmark. Treatment options for infections with ampicillin-resistant VRE are sparse, and there are no Danish guidelines concerning this topic. For treatment of uncomplicated VRE urinary tract infections, ciprofloxacin or nitrofurantoin can be used. The mainstay of treatment of bacteraemia and other severe infections caused by VRE is linezolid or high-dose daptomycin. Combination treatment is recommended for complicated infections and/or prolonged therapy.

Du skal være logget ind for at læse denne artikel
Log ind

Right side

af Knud Christian Christensen | 15/12
11 kommentarer
af Trine Cecilie Jeppesen | 15/12
1 Kommentar
af Lars Linnet | 14/12
1 Kommentar
af Niels Ejnar Bie | 14/12
1 Kommentar
af John Erik Bleibach | 14/12
1 Kommentar
af Mogens Stubkjær Hüttel | 14/12
35 kommentarer
af Lene Vejen Christiansen | 13/12
3 kommentarer
af Christian F. Asmussen | 13/12
7 kommentarer